Breezula from Italy Achieves Positive Results in Phase II Trial It was nearly 22 years ago that the FDA approved Propecia (finasteride) to slow or stop the rate of hair loss and regrow hair. That was the last time the FDA approved a medical treatment for hair loss, which is pretty amazing considering the flurry of discoveries related to hair ...
13.10.2021 · This will compare three different strengths of Breezula solution. The strengths are 2.5%, 5% and 7.5%. In total, the study will enroll 404 males with mild to moderate androgenetic alopecia, all of them in Germany. April 2019: Cassiopea announces the results of their highly anticipated range-finding study.
Apr 16, 2019 · Updated: CB0301 (Breezula/ Clascoterone) Phase 2 Results If you haven’t heard about it yet, CB0301 (brand name Breezula) is a topical anti-androgen that is being trialled for hair loss. It’s just finished phase 2 dose-ranging testing and shows promise.
16.04.2019 · The hair loss version – named Breezula – is not far behind either. Phase 2 trials for hair loss have just recently been completed. So… what were the results? CB0301 phase 2 trial results Initial results from the Phase 2 trial for androgenetic alopecia suggest CB0301 is slightly more effective than minoxidil:
Apr 16, 2019 · Based on these results, Cassiopea will proceed with a proof of concept clinical trial in women and an end of phase II meeting with the FDA in advance of the Phase III trials in men. About Clascoterone (Breezula®)
17.04.2019 · Cassiopea announces very positive Phase II Twelve Months Results for Breezula® (Clascoterone) in treating androgenetic alopecia. The presentation of the results is confusing, detailed, full of acronyms and somewhat open to interpretation. Note that “BID” in there stands for “twice per day” after conversion from Latin.
16.04.2019 · Efficacy Results The best performing group of the trial were the men who received the highest dose of 7.5% solution twice daily. This is a positive indication for the breezula drug because it shows that taking more of the drug causes more of the positive hair growth effect, also known as a “dose response.”
While all four groups who were treated with Breezula reported that hair loss slowed, there was marked improvement among the higher dosage (5 percent and 7.5 percent) groups. Perhaps equally exciting is that it worked relatively quickly, with statistically significant results starting at their 3-month checkups.
Apr 17, 2019 · Breezula Phase 3 trials have now been delayed till 4th quarter 2020 or 1st quarter 2021. All due to COVID-19 (Coronavirus), which has hit Italy particularly hard. More information can be found in Cassiopea’s 2019 Annual Results presentation, which was released today. The Clascoterone female pattern hair loss Phase 2 trials are on track to ...
My Testosterone results before and after Finasteride. Hello, I thought I would share my testosterone (Total T) results before and after taking Finasteride 1mg if anyone is interested. So here goes: Test before taking Fin (03/21/19) - 314 ng/dl or 10.9 nmol/l (Age 21) Test 2.5 months after starting Fin (07/15/19) - 586 ng/dl or 20.3 nmol/l (Age 21)